Fast-acting treatment for postpartum depression, if approved, could help hundreds of thousands of new mothers
A new treatment for postpartum depression, called brexanolone, is expected to be approved by the Food and Drug Administration this month.

from MarketWatch.com - Top Stories https://ift.tt/2TQYSCO
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2TQYSCO
via IFTTT
Kommentare
Kommentar veröffentlichen